Skip to main content
Public beta This website is in public beta – please give your feedback.

Example clinical scenario

A woman attends her routine fetal anomaly scan at 20 weeks, at which the sonographer identifies an anomaly in the chest. The stomach appears to be partially above the diaphragm, protruding into the chest cavity and the heart appears pushed towards the baby’s right side. The sonographer suspects a congenital diaphragmatic hernia (CDH) and refers to antenatal clinic for ongoing management. 

When to consider genomic testing

  • If a CDH is identified on ultrasound, an amniocentesis or chorionic villus sample should be considered to allow for genomic testing.
  • Around 30% of CDH cases have a genetic cause. The chance is more likely where there are additional or associated anomalies.

What do you need to do?

  • Refer to local guidance regarding fetal medicine referral. Further review in a fetal medicine unit is usually warranted. Women should also be referred for a fetal echocardiogram to assess the baby’s cardiac structure.
  • A fetal medicine review will determine whether genomic testing is appropriate, and referral to clinical genetics will be considered.
  • The relevant team will refer to the NHS England National Genomic Test Directory eligibility criteria to determine which tests are available for your patient. The directory itself provides a list of all available tests.
  • Decide which testing is most suitable for the specific clinical scenario and for your patient.
  • Depending on the clinical scenario, a range of different genomic tests may be considered:
  • Information about patient eligibility and test indications was correct at the time of writing. When requesting a test, please refer to the National Genomic Test Directory to confirm the right test for your patient.

Resources

For clinicians

For patients

↑ Back to top
  • Last reviewed: 22/03/2023
  • Next review due: 22/03/2024
  • Authors: Emily Fadipe
  • Reviewers: Dr Andrew Breeze, Dr Jessica Woods